Recommended Alerts

Sign Up For Alerts

A new dawn for regulation of medical technologies in the UK post-Brexit? From European directives to the proposed stand-alone regulatory regime for the future

Last month the Medicines and Healthcare products Regulatory Agency launched a public consultation on the future of medical device regulation in the UK.

Read More

Second Circuit Holds First Amendment Bars Conviction Based Solely on Off-Label Promotion of FDA-Approved Drug

Practices: Life Sciences, Corporate & Securities Litigation, Government Enforcement / White Collar Criminal Defense, Appellate & Supreme Court, Securities & Public Companies Industries: Biotechnology & Pharmaceuticals

Printer-Friendly Version

Cookie Settings